Therapy of migraine attacks and migraine prophylaxis - Recommendations by the German Society for Migraine and Headache (DMKG);Therapie der Migraneattacke und Migraneprophylaxe: Empfehlungen der Deutschen Migrane- und Kopfschmerzgesellschaft (DMKG)

Aktuelle Neurologie

Volumn 27, Issue 6, 2000, Pages 273-282

  Diener, H C ^a   Brune, K ^b   Gerber, W D ^c   Pfaffenrath, V ^d   Straube, A ^e  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d Neurologe   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; ANTIMIGRAINE AGENT; BELOC ZOK; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLANDELATE; DIHYDROERGOTAMINE; DIHYDROERGOTAMINE MESILATE; DOMPERIDONE; ELETRIPTAN; ERGO SANOL; ERGOTAMINE DERIVATIVE; ERGOTAMINE TARTRATE; FLUNARIZINE; IBUPROFEN; LISURIDE MALEATE; MAGNESIUM; METOCLOPRAMIDE; METOPROLOL; NAPROXEN; NARATRIPTAN; PARACETAMOL; PIZOTIFEN; PROPRANOLOL; RIZATRIPTAN; SEROTONIN AGONIST; SUMATRIPTAN SUCCINATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; ZOLMITRIPTAN;

COGNITIVE THERAPY; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG INDUCED DISEASE; HEADACHE; HUMAN; MIGRAINE; MIGREXA; PAIN; RELAXATION TRAINING; REVIEW; VOMITING;

EID: 0033811287     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1017554     Document Type: Review

References (105)

1. Behandlung der Migraneattacke und Migraneprophylaxe
2. Epidemiology of headache
3. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
4. Pediatric migraine and the International Headache Society (IHS) criteria
5. 'Menstrual' migraine: Towards a definition
6. Migraine and concomitant symptoms among 8167 adult twin pairs
7. Evidence of a genetic factor in migraine with aura: A population-based danish twin study
8. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4
9. A new locus for hemiplegic migraine maps to chromosome 1q31
10. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity
11. The relative role of genetic and environmental factors in migraine without aura
12. Familial typical migraine: Linkage to chromosome 19p13 and evidence for genetic heterogenity
13. Chinook winds and migraine headache
14. Technische Zusatzuntersuchungen bei Kopfschmerzen: Was ist notwendig und erforderlich?
15. The methods used in clinical trials of sumatriptan in migraine
16. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine
17. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine
18. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine
19. Migraine and cluster headache - Their management with sumatriptan: A critical review of the current clinical experience
20. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: A systematic review based on numbers needed to treat
21. Risk factors for headache recurrence after sumatriptan: A study in 366 migraine patients
22. Sumatriptan misuse in daily chronic headache
23. Sumatriptan and ergotamine overuse and drug-induced headache: A clinicoepidemiologic study
24. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan
25. Cardiovascular safety of 5-HT(1B/1D) agonists - Is there a cause for concern?
26. Therapie der akuten Migraneattacke: Kampf der 'Triptane'
27. Acute management of migraine: Triptans and beyond
28. Antimigraine drugs
29. Treatment of migraine attacks with sumatriptan
30. Sumatriptan nasal spray for the acute treatment of migraine
31. Sumatriptan suppositories for the acute treatment of migraine
32. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: Defining the optimum doses of oral sumatriptan
33. Naratriptan is effective and well tolerated in the acute treatment of migraine
34. Naratriptan
35. Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: An overview of efficacy
36. A review of the efficacy of zolmitriptan (311C90): A new treatment for migraine
37. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study
38. Efficacy and safety of rizatriptan wafer for the acute treatment of migraine
39. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 and 50 mg in migraine
40. Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine
41. Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study
42. Evidence for the improved efficacy and safety of eletriptan compared with sumatriptan
43. Placebo-controlled clinical trials with ergotamine in the acute treatment of migraine
44. Ergotamine in the acute treatment of migraine. A review and European consensus
45. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine
46. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine
47. Analgetika-induzierter Dauerkopfschmerz
48. The effect of metoclopramide on the absorption of effervescent aspirin in migraine
49. The efficacy of metoclopramide in the treatment of migraine headache
50. Acetylsalicylic acid in the treatment of headache
51. Safety and efficacy of combined lysine acetylsalicylate and metoclopramide: Repeat intakes in migraine attacks
52. Treatment of acute migraine attack: Ibuprofen and placebo compared
53. Low-dose ibuprofen in self-medication of mild to moderate headache: A comparison with acetylsalicylic acid and placebo
54. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain - Three double-blind, randomized, placebo-controlled trials
55. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine
56. Acute treatment of migraine attacks: Efficacy and safety of a nonsteroidal antiinflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo
57. Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks
58. Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks
59. Tolfenamic acid decreases migraine recurrence when used with sumatriptan
60. Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: Comparable effect in a double-blind, randomized, controlled, parallel-group study
61. The efficacy and safety of intavenous acetylsalicyclic lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomised, multicenter, parallel group study
62. Practice parameter: Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus
63. Butorphanol (Stadol): A study in problems of current drug information and control
64. Headaches and women: Treatment of the pregnant and lactating migraineur
65. The pharmacotherapy of migraine in pregnancy
66. Migraine and pregnancy
67. Intranasal sumatriptan for the acute treatment of migraine in children
68. Propranolol in the management of recurrent migraine: A meta-analytic review
69. Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study
70. Metoprolol and propranolol in migraine prophylaxis: A double-blind multicenter study
71. Flunarizine versus metoprolol in migraine prophylaxis: A double-blind, randomized parallel group study of efficacy and tolerability
72. Metoprolol in the prophylaxis of migraine: Parallel group comparison with placebo and dose-ranging follow-up
73. Prophylactic treatment of migraine with bisoprolol: A placebo-controlled study
74. Bisoprolol and metoprolol in the prophylactic treatment of migraine with and without aura - A randomized double-blind cross-over multicenter study
75. Flunarizine vs propranolol: A meta-analysis of clinical trials
76. Valproinsaure in der prophylaktischen Behandlung der Migrane
77. Valproinsaure in der Migraneprophylaxe
78. Divalproex sodium in migraine prophylaxis: A dose-controlled study
79. Migraine prophylaxis with divalproex
80. Methysergide
81. Prophylaxis of migraine with oral magnesium: Results from a prospective, multi-center, placebo-controlled and double-blind randomized study
82. Magnesium in the prophylaxis of migraine - A double-blind, placebo-controlled study
83. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura
84. α-Dihydroergocryptine in the prophylaxis of migraine: A multicenter double-blind study versus flunarizine
85. Behavioral management of migraine
86. Behavioural and prophylactic intervention studies of pediatric migraine: An exploratory meta-analysis
87. Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: A meta-analytic review of clinical trials
88. Psychosocial interventions in the management of recurrent headache disorders: Overview and effectiveness
89. Psychological treatments for migraine
90. Long-term effects of biofeedback on migraine headache: A prospective follow-up study
91. Bewegungs- und Sporttherapie bei chronischen Kopfschmerzen
92. Exercise and migraine: A critical review
93. Transkutane elektrische Nervenstimulation (TENS) bei Kopf- und Gesichtsschmerzen
94. Grundlagen fur den Einsatz von Physiotherapie bei primaren Kopfschmerzen
95. Classical homeopathic treatment of chronic headaches
96. Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine
97. Homeopathic prophylaxis of headache and migraine. A systematic review
98. Acupuncture for recurrent headaches: A systematic review of randomized controlled trials
99. Feverfew - Eine Alternative bei Migrane